Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The enormous success of ACE inhibitors in hypertension and heart failure ...

A study, led by University of Iowa researchers, reveals a new dimension for a key heart enzyme and sheds light on an important biological pathway involved in cell death in heart disease. The study, ...

Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers are used commonly in clinical practice to treat hypertension and decrease cardiovascular events in high-risk patients.

In the search for treatments for COVID-19, many researchers are focusing their attention on a specific protein that allows the virus to infect human cells. Called the angiotensin-converting enzyme 2, ...

March 23, 2012 — Results of a small study provide more evidence that antihypertensive therapy with angiotensin-receptor blockers (ARBs) has benefits on cognitive function in older adults with early ...

Researchers have discovered a new signaling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. Researchers in ...

Two small companies developing therapeutic vaccines against hypertension are blazing a trail for immune treatments that address diseases of lifestyle with massive markets. But doubts linger over the ...

Mineralocorticoid receptor antagonists (MRAs) are still finding their place in nephrology. Many of us relegate them to the bottom of our therapeutic bag for use only after we've exhausted other ...

Researchers at the University of Campinas (UNICAMP) in São Paulo State, Brazil, have identified molecules that serve as markers of Zika in blood serum taken from patients with this viral infection.